Labroots
Home  >  Suppliers  >  Innovative Research, Inc

Filter your search

Clear All Filters / Fresh Search

Newsletter Signup Filter Facebook Like Us Absave Sale Labsave Absave Filter

Innovative Research, Inc

Supplier Rating:
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 Reviews
Human PAI-1 (N-terminal fluorecein labeled, active) 1mg
Human PAI-1 (N-terminal fluorecein labeled, active) 1mg
Innovative Research, Inc

Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Human PAI-1 (N-terminal fluorecein labeled, active) 0.5mg
Human PAI-1 (N-terminal fluorecein labeled, active) 0.5mg
Innovative Research, Inc

Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Human PAI-1 (N-terminal fluorecein labeled, latent fraction) 1mg
Human PAI-1 (N-terminal fluorecein labeled, latent fraction) 1mg
Innovative Research, Inc

Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Human PAI-1 (N-terminal fluorecein labeled, latent fraction) 0.5mg
Human PAI-1 (N-terminal fluorecein labeled, latent fraction) 0.5mg
Innovative Research, Inc

Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Human PAI-1 (N-terminal fluorecein labeled stable mutant) 1mg
Human PAI-1 (N-terminal fluorecein labeled stable mutant) 1mg
Innovative Research, Inc

Stable mutant human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Human PAI-1 (N-terminal fluorecein labeled stable mutant) 0.5mg
Human PAI-1 (N-terminal fluorecein labeled stable mutant) 0.5mg
Innovative Research, Inc

Stable mutant human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Human PAI-1 (vitronectin null binding mutant) 1mg
Human PAI-1 (vitronectin null binding mutant) 1mg
Innovative Research, Inc

A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological...

Human PAI-1 (vitronectin null binding mutant) 0.5mg
Human PAI-1 (vitronectin null binding mutant) 0.5mg
Innovative Research, Inc

A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological...

Human PAI-1 (NBD labeled mutant) 1mg
Human PAI-1 (NBD labeled mutant) 1mg
Innovative Research, Inc

This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to...

Human PAI-1 (NBD labeled mutant) 0.5mg
Human PAI-1 (NBD labeled mutant) 0.5mg
Innovative Research, Inc

This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to...

Human PAI-1 tPA complex 0.1mg
Human PAI-1 tPA complex 0.1mg
Innovative Research, Inc

Human PAI-1 stable mutant is reacted with an excess of human sc-tPA at physiological pH. The resulting 1:1 molar complex is purified from the remaining tPA...

Human PAI-1 uPA complex 0.1mg
Human PAI-1 uPA complex 0.1mg
Innovative Research, Inc

Human PAI-1 stable mutant is reacted with an excess of human urokinase at physiological pH. Excess uPA is removed from the resulting 1:1 molar complex by...

Human PAI -1 Elastase Specific Mutant For in Vivo Studies 0.5mg
Human PAI -1 Elastase Specific Mutant For in Vivo Studies 0.5mg
Innovative Research, Inc

This human PAI-1 variant contains a mutation at the active site to make it specific for inhibition of neutrophil elastase. Additional mutations provide...

Human PAI -1 Elastase Specific Mutant 1mg
Human PAI -1 Elastase Specific Mutant 1mg
Innovative Research, Inc

A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is...

Human PAI -1 Elastase Specific Mutant 0.5mg
Human PAI -1 Elastase Specific Mutant 0.5mg
Innovative Research, Inc

A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is...

Human PAI -1 Cathepsin G Specific Mutant 1mg
Human PAI -1 Cathepsin G Specific Mutant 1mg
Innovative Research, Inc

A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to Cathepsin G.

Human PAI -1 Cathepsin G Specific Mutant 0.5mg
Human PAI -1 Cathepsin G Specific Mutant 0.5mg
Innovative Research, Inc

A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to Cathepsin G.

Rat PAI-1 (wild type active form) 1mg
Rat PAI-1 (wild type active form) 1mg
Innovative Research, Inc

Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains...

Rat PAI-1 (wild type active form) 0.5mg
Rat PAI-1 (wild type active form) 0.5mg
Innovative Research, Inc

Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains...

Rat PAI-1 (wild type latent form) 1mg
Rat PAI-1 (wild type latent form) 1mg
Innovative Research, Inc

Latent rat PAI-1 is a useful control for experiments when used in conjunction with the active form or stable mutant.